Green Cross’s Hunterase gets orphan drug designation from US FDA
The company plans to file the New Drug Application (NDA) for Hunterase within this year.
Under the U.S. law, companies that develop such a drug (a drug ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
